Registration and abstract submission now open
The 22nd CIMT Annual Meeting will again feature the latest breakthroughs in translational cancer immunotherapy research, with a program that spans innovative therapies, advances for precise patient selection, and in-depth insights into immune-cancer interactions. Sessions will include focused discussions on Improving Immunity, Tumor Microenvironment, New Targets, Cellular Therapies, Artificial Intelligence, and the emerging field of Neuro-Oncoimmunology.